Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at adding pembrolizumab to other cancer treatments for people with prostate cancer that has spread (KEYNOTE-365)

Overview

Cancer types:

Prostate cancer, Secondary cancers

Status:

Open

Phase:

Phase 1/2

Details

This trial is looking at a drug called pembrolizumab in combination with other drugs in prostate cancer.

It is for people with metastatic castration resistant prostate cancer (mCRPC). This means that the cancer:

  • has spread to other parts of the body (advanced prostate cancer)

  • got worse despite having hormone treatment

Recruitment start: 1 February 2017

Recruitment end: 22 October 2027

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Johann DeBono

Supported by

Merck Sharp & Dohme LLC

Last reviewed: 15 Jun 2025

CRUK internal database number: 17603

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.